カテゴリー： Inkwood Research, アジア太平洋, 産業機械/建設

アジア太平洋の3Dバイオプリンティング市場2023-2032

◆英語タイトル：ASIA-PACIFIC 3D BIOPRINTING MARKET FORECAST 2023-2032

Inkwood Researchが発行した調査報告書（INK23JUL018）◆商品コード：INK23JUL018
◆発行会社（リサーチ会社）：Inkwood Research
◆発行日：2023年4月3日
◆ページ数：152
◆レポート形式：英語 / PDF
◆納品方法：Eメール
◆調査対象地域：アジア太平洋
◆産業分野：産業装置
◆販売価格オプション（消費税別）
Single UserUSD1,250 ⇒換算￥190,000見積依頼/購入/質問フォーム
Multi LicenseUSD1,500 ⇒換算￥228,000見積依頼/購入/質問フォーム
Enterprisewide PriceUSD2,000 ⇒換算￥304,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Inkwood Research社の本調査資料では、3Dバイオプリンティングのアジア太平洋市場が2023年〜2032年の間に年平均成長率16.81%を記録すると予測しています。本資料は、3Dバイオプリンティングのアジア太平洋市場について調べ、調査範囲・調査手法、エグゼクティブサマリー、市場動向、主要分析、コンポーネント別（3Dバイオプリンタ、バイオインク）分析、生体材料別（ハイドロゲル、生細胞、細胞外マトリックス、その他）分析、技術別（磁気浮上型バイオプリンティング、インクジェット型バイオプリンティング、シリンジ/押出型バイオプリンティング、レーザー支援バイオプリンティング、その他）分析、用途別（医薬品試験・開発、組織エンジニアリング・再生医療、食品検査、研究、その他）分析、地域別（中国、日本、インド、韓国、シンガポール、タイ、オーストラリア・ニュージーランド、その他地域）分析、競争状況などの項目を掲載しています。また、3D BIOPRINTING SOLUTIONS、ADVANCED SOLUTIONS LIFE SCIENCES、ALLEVI、CELLINK、COLLPLANT BIOTECHNOLOGIES LTD、CYFUSE BIOMEDICAL KKなどの企業情報が含まれています。
・調査範囲・調査手法
・エグゼクティブサマリー
・市場動向
・主要分析
・アジア太平洋の3Dバイオプリンティング市場規模：コンポーネント別
- 3Dバイオプリンタの市場規模
- バイオインクの市場規模
・アジア太平洋の3Dバイオプリンティング市場規模：生体材料別
- ハイドロゲルにおける市場規模
- 生細胞における市場規模
- 細胞外マトリックスにおける市場規模
- その他生体材料における市場規模
・アジア太平洋の3Dバイオプリンティング市場規模：技術別
- 磁気浮上型バイオプリンティングの市場規模
- インクジェット型バイオプリンティングの市場規模
- シリンジ/押出型バイオプリンティングの市場規模
- レーザー支援バイオプリンティングの市場規模
- その他技術の市場規模
・アジア太平洋の3Dバイオプリンティング市場規模：用途別
- 医薬品試験・開発における市場規模
- 組織エンジニアリング・再生医療における市場規模
- 食品検査における市場規模
- 研究における市場規模
- その他用途における市場規模
・アジア太平洋の3Dバイオプリンティング市場規模：地域別
- 中国の3Dバイオプリンティング市場規模
- 日本の3Dバイオプリンティング市場規模
- インドの3Dバイオプリンティング市場規模
- 韓国の3Dバイオプリンティング市場規模
- シンガポールの3Dバイオプリンティング市場規模
- タイの3Dバイオプリンティング市場規模
- オーストラリア・ニュージーランドの3Dバイオプリンティング市場規模
- その他地域の3Dバイオプリンティング市場規模
・競争状況

KEY FINDINGS
The Asia-Pacific 3D bioprinting market is expected to register a CAGR of 16.81% during the forecast period, 2023-2032. The industrial aspects of gene therapy have garnered attention in Korea, Japan, and China, leading to the establishment of several start-ups and a lucrative environment in terms of investments. As a result, the surging demand for gene therapies indirectly boosts the demand for 3D-printed products in the region.

MARKET INSIGHTS
China, South Korea, Australia & New Zealand, Thailand, Japan, India, Singapore, and Rest of Asia-Pacific are evaluated for the Asia-Pacific 3D bioprinting market growth assessment. In India, the government promotes research & development initiatives in regenerative medicine (RM). Also, several complex interlinkages among governments, academia, and industry have facilitated the development of innovative capacity. This is evident in initiatives associated with tissue engineering, gene therapy, stem cell & cord blood banking, gene therapy, 3D bioprinting, and biomaterials.
In Singapore, researchers at the Singapore Institute of Manufacturing Technology were able to create realistic colorations on printed samples by regulating melanin production in bioink (November 2019). In August 2020, researchers from the Singapore University of Technology and Design (SUTD) demonstrated a new level of control in the directed differentiation of stem cells by means of a printed micro-scaled physical device. Moreover, the Nanyang Technological University Singapore (NTU Singapore) scientists used sunflower pollen to develop a 3D printing ink material that can be used to fabricate parts useful for drug delivery, toxicity testing, and tissue engineering. Such factors offer growth opportunities for the analyzed market in these countries.

COMPETITIVE INSIGHTS
Some of the leading companies in the market are ROKIT Healthcare Inc, Organovo Holdings Inc, GeSiM GmbH, etc.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation caters to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

❖ レポートの目次 ❖

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
2.4.1. IMPACT OF COVID-19 ON 3D BIOPRINTING MARKET
2.5. MAJOR MARKET FINDINGS
2.5.1. EMERGENCE OF 4D BIOPRINTING AS A SUBSTITUTE FOR 3D BIOPRINTING
2.5.2. PERSONALIZED MEDICINE LIKELY TO BOOST 3D BIOPRINTING
2.5.3. RISING INTEREST IN THE APPLICATION OF BIOPRINTING AGAINST THE SARS-COV-2 VIRUS
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. SURGING GERIATRIC POPULATION
3.1.2. TECHNOLOGICAL ADVANCEMENTS AND R&D INVESTMENTS
3.1.3. RISING FOCUS ON REGENERATIVE MEDICINE
3.1.4. HIGH PREVALENCE OF CHRONIC CONDITIONS
3.2. KEY RESTRAINTS
3.2.1. OPERATIONAL CHALLENGES DURING MANUFACTURING
3.2.2. EXORBITANT COSTS OF 3D BIOPRINTERS
3.2.3. LACK OF TRAINED PROFESSIONALS
4. KEY ANALYTICS
4.1. PARENT MARKET ANALYSIS
4.2. KEY MARKET TRENDS
4.3. PORTER’S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRANTS
4.3.5. INDUSTRY RIVALRY
4.4. GROWTH PROSPECT MAPPING
4.4.1. GROWTH PROSPECT MAPPING IN CHINA
4.5. MARKET MATURITY ANALYSIS
4.6. MARKET CONCENTRATION ANALYSIS
4.7. VALUE CHAIN ANALYSIS
4.7.1. DESIGN & SOFTWARE PROVIDERS
4.7.2. PROTOTYPE PRODUCTION
4.7.3. DISTRIBUTION
4.7.4. END-USERS
5. MARKET BY COMPONENT
5.1. 3D BIOPRINTER
5.2. BIOINK
6. MARKET BY BIOMATERIAL
6.1. HYDROGEL
6.2. LIVING CELLS
6.3. EXTRACELLULAR MATRICES
6.4. OTHER BIOMATERIALS
7. MARKET BY TECHNOLOGY
7.1. MAGNETIC LEVITATION BIOPRINTING
7.2. INKJET-BASED BIOPRINTING
7.3. SYRINGE/EXTRUSION-BASED BIOPRINTING
7.4. LASER-ASSISTED BIOPRINTING
7.5. OTHER TECHNOLOGIES
8. MARKET BY APPLICATION
8.1. DRUG TESTING & DEVELOPMENT
8.2. TISSUE ENGINEERING & REGENERATIVE MEDICINE
8.3. FOOD TESTING
8.4. RESEARCH
8.5. OTHER APPLICATIONS
9. MARKET BY END-USER
9.1. HOSPITALS
9.2. BIOPHARMACEUTICALS COMPANIES
9.3. RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES
9.4. OTHER END-USERS
10. GEOGRAPHICAL ANALYSIS
10.1. ASIA-PACIFIC
10.1.1. MARKET SIZE & ESTIMATES
10.1.2. ASIA-PACIFIC 3D BIOPRINTING MARKET DRIVERS
10.1.3. ASIA-PACIFIC 3D BIOPRINTING MARKET CHALLENGES
10.1.4. ASIA-PACIFIC 3D BIOPRINTING MARKET REGULATORY FRAMEWORK
10.1.5. KEY PLAYERS IN ASIA-PACIFIC 3D BIOPRINTING MARKET
10.1.6. COUNTRY ANALYSIS
10.1.6.1. CHINA
10.1.6.1.1. CHINA 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
10.1.6.2. JAPAN
10.1.6.2.1. JAPAN 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
10.1.6.3. INDIA
10.1.6.3.1. INDIA 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
10.1.6.4. SOUTH KOREA
10.1.6.4.1. SOUTH KOREA 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
10.1.6.5. SINGAPORE
10.1.6.5.1. SINGAPORE 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
10.1.6.6. THAILAND
10.1.6.6.1. THAILAND 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
10.1.6.7. AUSTRALIA & NEW ZEALAND
10.1.6.7.1. AUSTRALIA & NEW ZEALAND 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
10.1.6.8. REST OF ASIA-PACIFIC
10.1.6.8.1. REST OF ASIA-PACIFIC 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
11. COMPETITIVE LANDSCAPE
11.1. KEY STRATEGIC DEVELOPMENTS
11.1.1. MERGERS & ACQUISITIONS
11.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
11.1.3. PARTNERSHIPS & AGREEMENTS
11.2. COMPANY PROFILES
11.2.1. 3D BIOPRINTING SOLUTIONS
11.2.1.1. COMPANY OVERVIEW
11.2.1.2. PRODUCTS LIST
11.2.2. ADVANCED SOLUTIONS LIFE SCIENCES
11.2.2.1. COMPANY OVERVIEW
11.2.2.2. PRODUCTS LIST
11.2.3. ALLEVI
11.2.3.1. COMPANY OVERVIEW
11.2.3.2. PRODUCTS LIST
11.2.4. CELLINK
11.2.4.1. COMPANY OVERVIEW
11.2.4.2. PRODUCTS LIST
11.2.4.3. STRENGTHS & CHALLENGES
11.2.5. COLLPLANT BIOTECHNOLOGIES LTD
11.2.5.1. COMPANY OVERVIEW
11.2.5.2. PRODUCTS LIST
11.2.6. CYFUSE BIOMEDICAL KK
11.2.6.1. COMPANY OVERVIEW
11.2.6.2. PRODUCTS LIST
11.2.6.3. STRENGTHS & CHALLENGES
11.2.7. ENVISIONTEC ṁ INC
11.2.7.1. COMPANY OVERVIEW
11.2.7.2. PRODUCTS LIST
11.2.7.3. STRENGTHS & CHALLENGES
11.2.8. GESIM GMBH
11.2.8.1. COMPANY OVERVIEW
11.2.8.2. PRODUCTS LIST
11.2.8.3. STRENGTHS & CHALLENGES
11.2.9. INVENTIA LIFE SCIENCE PTY LTD
11.2.9.1. COMPANY OVERVIEW
11.2.9.2. PRODUCTS LIST
11.2.10. ORGANOVO HOLDINGS INC
11.2.10.1. COMPANY OVERVIEW
11.2.10.2. PRODUCTS LIST
11.2.10.3. STRENGTHS & CHALLENGES
11.2.11. REGEMAT 3D
11.2.11.1. COMPANY OVERVIEW
11.2.11.2. PRODUCTS LIST
11.2.11.3. STRENGTHS & CHALLENGES
11.2.12. REGENHU
11.2.12.1. COMPANY OVERVIEW
11.2.12.2. PRODUCTS LIST
11.2.12.3. STRENGTHS & CHALLENGES
11.2.13. REVOTEK CO LTD
11.2.13.1. COMPANY OVERVIEW
11.2.13.2. PRODUCTS LIST
11.2.14. ROKIT HEALTHCARE INC
11.2.14.1. COMPANY OVERVIEW
11.2.14.2. PRODUCTS LIST
11.2.15. STRATASYS LTD
11.2.15.1. COMPANY OVERVIEW
11.2.15.2. PRODUCTS LIST

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – 3D BIOPRINTING
TABLE 2: COMPARATIVE SUMMARY OF 3D BIOPRINTING TECHNOLOGIES
TABLE 3: LIST OF APPROVED TISSUE-ENGINEERED MEDICAL PRODUCTS (TEMPS) USED IN VARIOUS COUNTRIES
TABLE 4: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY COMPONENT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 5: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY COMPONENT, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 6: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY BIOMATERIAL, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 7: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY BIOMATERIAL, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 8: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 9: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY TECHNOLOGY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 10: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 11: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY APPLICATION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 12: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY END-USER, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 13: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY END-USER, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 14: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 15: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 16: ASIA-PACIFIC 3D BIOPRINTING MARKET REGULATORY FRAMEWORK
TABLE 17: KEY PLAYERS OPERATING IN ASIA-PACIFIC 3D BIOPRINTING MARKET
TABLE 18: LIST OF MERGERS & ACQUISITIONS
TABLE 19: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 20: LIST OF PARTNERSHIPS & AGREEMENTS


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ アジア太平洋の3Dバイオプリンティング市場2023-2032(ASIA-PACIFIC 3D BIOPRINTING MARKET FORECAST 2023-2032)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 世界の3Dバイオプリンティング市場2023-2032
  • アジア太平洋の煙感知器市場2023-2032
  • アジア太平洋のUV（紫外線）消毒装置市場2023-2032
  • アジア太平洋のフレキシブルエレクトロニクス市場2023-2032
  • アジア太平洋の産業用ロボット市場2024-2032

    • ◆H&Iグローバルリサーチのお客様（例）◆